(Update) Report on Symposium “Global Health and Corporate Strategy: Varied and Innovative Models”
date : 12/25/2012
The symposium “Global Health and Corporate Strategy: Varied and Innovative Models” was hosted in collaboration with the GAVI Alliance and UNICEF Tokyo Office.
With
the IMF/World Bank annual general meetings was held in Tokyo in October,
attention was drawn toward the major agenda of investments into health. Under
this increased momentum, the emphasis at this symposium was on partnerships
within corporations and various organizations particularly for the solving of
global health problems. The merits, barriers and solutions to such partnerships
was discussed through the sharing of successful examples, and with a focus on
the impact produced by international social action that utilized the special
features of businesses and varied and innovative approaches it was aspired to
help solve global health problems.
(Please download our report, program and questionnaire from the right )
(You can see some parts of videos on the day from here (YouTube).)
GAVI – HGPI – UNICEF Collaborative Symposium
“Global Health and Corporate Strategy: Diverse, Innovative Partnership Models”
■Date : Thursday, October 11, 2012 from 15:00~18:00
■Venue : Fujifilm
Corporation / Midtown West Conference room (2F)
■Co-organizers: GAVI Alliance/ Health and Global Policy Institute (HGPI)/
UNICEF Tokyo Office
■Supported by the
Ministry of Foreign Affairs of Japan
■In cooperation with : RESULTS Japan
■Program
1. Opening Remarks(15:00-15:10)
– Dr. Seth Berkley (CEO, GAVI Alliance)
2. Keynote Speeches
Keynote Speeches 1(15:10-15:40)
–
Dr. Kiyoshi Kurokawa (Chairman, HGPI)
Keynote Speeches 2(15min.)
–
Dr. Tadataka Yamada(Member of the Board, Chief Medical & Scientific
Officer, Takeda Pharmaceutical Company Limited)
Break (15:40-16:00)
3. Panel Discussion: Multi-Stakeholder Partnerships in Global
Health(16:00-17:40)
Moderator: Mr. Koichi Kaneda (Senior Director, Corporate Social
Responsibility, Corporate Communication, Takeda Pharmaceutical Company Limited)
1) “Partnership Case Study –Ghana Project–”
– Dr. Yasuhiko Toride, Director of Nutrition Improvement
Projects / Associate General Manager, R&D Planning Dept., Ajinomoto Co.,
Inc.
2) “Partnership Case Study –Anti-Infective Drug–”
– Dr. Junichi Mitsuyama, Senior Operations Manager, FUJIFILM
Corporation / Director, Toyama Chemical Co., Ltd.
3) “Partnership Case Study –Vaccine &
Medicine Development for NTDs through Partnership–“
– Dr.
BT Slingsby (Director of Global Access Strategies,
Eisai Co., Ltd.)
4) “Partnership Case Study –Vaccine Bonds–”
– Mr. Satoru Yamamoto, Director, Head of International
Investors Services, FICC Sales Dept (I), Daiwa Securities
5) “Promoting Global Partnership for
Children–Case Studies and Considerations–”
– Dr. Kunihiko Chris Hirabayashi (Director, United Nations Children’s Fund Tokyo office)
Discussion (50 min)
4. Wrap-up(17:40-17:55)
– Dr. Seth Berkley (CEO, GAVI Alliance)
– Dr. Dr. Tadataka Yamada(Member of the Board, Chief Medical & Scientific
Officer, Takeda Pharmaceutical Company Limited)
– Dr. Kiyoshi Kurokawa (Chairman, HGPI)
5. Closing Remarks
– Dr.
Shiro Konuma (Director, Global Health Policy Division International Cooperation Bureau
Ministry of Foreign Affairs)(17:55-18:00)
Contact Details:
GAVI – HGPI – UNICEF Collaborative Symposium Japan Secretariat
Health and Global Policy Institute
1-11-28 Nagatacho,Chiyoda-Ku Tokyo 100-0014 Japan
E-mail: symposium1011@hgpi.org
Normal 0 0 2 false false false EN-US JA X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:標準の表; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:””; mso-padding-alt:0mm 5.4pt 0mm 5.4pt; mso-para-margin:0mm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.5pt; mso-bidi-font-size:11.0pt; font-family:”Century”,”serif”; mso-ascii-font-family:Century; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:Century; mso-hansi-theme-font:minor-latin; mso-font-kerning:1.0pt;}
Registration deadline: 2012-10-09
Exhibition date:2012-10-11
Top Research & Recommendations Posts
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] The Path to a Sustainable Healthcare System: Three Key Objectives for Public Deliberation (January 22, 2026)
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Recommendations] “Balancing Sustainability and Innovation in the Healthcare System” (December 26, 2025)
- [Publication Report] Planetary Health Promotion Project “Issues Facing Planetary Health and the Role of the Health Sector” (May 10, 2023)
Featured Posts
-
2026-01-09
[Registration Open] (Hybrid Format) Dementia Project FY2025 Initiative Concluding Symposium “The Future of Dementia Policy Surrounding Families and Others Who Care for People with Dementia” (March 9, 2026)
-
2026-01-22
[Policy Recommendations] The Path to a Sustainable Healthcare System: Three Key Objectives for Public Deliberation (January 22, 2026)
-
2026-01-26
[HGPI Policy Column] (No.68) – From the Intractable and Rare Diseases Project “Part 2 – Making Intractable and Rare Diseases a Priority Issue for the International Community: The WHA Resolution’s Vision for a Global Action Plan and Japan’s Role”
-
2026-01-26
[Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)



